Atom | Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional)

Funder: National Institutes of Health (NIH)

Due Dates: November 17, 2025

Funding Amounts: Award size varies by project scope; U44 cooperative agreement, multi-year funding available

Summary: Supports biologic-based therapeutic discovery and development for nervous system disorders, from lead optimization through Phase I clinical testing.

Key Information: Small businesses only; foreign organizations not eligible to apply.

Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional)

Sign in to see full grant listing